First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC

JOURNAL ARTICLE published April 2014 in British Journal of Cancer

Authors: J J Ko | T K Choueiri | B I Rini | J-L Lee | N Kroeger | S Srinivas | L C Harshman | J J Knox | G A Bjarnason | M J MacKenzie | L Wood | U N Vaishampayan | N Agarwal | S K Pal | M-H Tan | S Y Rha | T Yuasa | F Donskov | A Bamias | D Y C Heng